| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 |
|---|---|---|---|---|---|---|---|---|
Operating expenses: | ||||||||
Research and development | ||||||||
10,335 | 12,595 | 12,157 | 9,343 | 7,563 | 7,877 | 6,147 | 6,007 | 5,455 |
General and administrative | ||||||||
4,125 | 2,745 | 4,840 | 4,728 | 3,468 | 1,286 | 2,087 | 2,901 | 2,136 |
Total operating expenses | ||||||||
14,460 | 15,340 | 16,997 | 14,071 | 11,031 | 9,163 | 8,234 | 8,908 | 7,591 |
Loss from operations | ||||||||
-14,460 | -15,340 | -16,997 | -14,071 | -11,031 | -9,163 | -8,234 | -8,908 | -7,591 |
Other income (expense): | ||||||||
Interest income | ||||||||
257 | - | - | - | 390 | - | - | - | - |
Interest income (expense), net | ||||||||
- | - | -307 | -376 | - | - | -555 | -519 | -546 |
Other income (expense) | ||||||||
-4 | -915 | -307 | -376 | 0 | -599 | -550 | -515 | -509 |
Change in fair value of preferred stock warrant liability | ||||||||
0 | 0 | 0 | 0 | 51 | 60 | -5 | -4 | -37 |
Interest expense | ||||||||
802 | - | - | - | 881 | - | - | - | - |
Total other income (expense), net | ||||||||
-549 | - | - | - | -542 | - | - | - | - |
Net loss and comprehensive loss | ||||||||
-15,009 | -15,713 | -17,304 | -14,447 | -11,573 | -9,762 | -8,784 | -9,423 | -8,100 |
Net loss per share, basic and diluted (USD per share) | ||||||||
-0.65 | 0.58 | -0.75 | -0.95 | -2.43 | -2.05 | -1.85 | -2.15 | -1.92 |
Weighted average common shares outstanding, basic and diluted (in shares) | ||||||||
23,188 | 23,409 | 23,083 | 15,230 | 4,775 | 4,781 | 4,769 | 4,405 | 4,229 |